Holen Sie sich die Stockscreener-App
23.20
0.01%
0.0012
Handel nachbörslich:
22.96
-0.2359
-1.02%
Schlusskurs vom Vortag:
$23.19
Offen:
$23.32
24-Stunden-Volumen:
3,193
Relative Volume:
0.27
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.59%
1M Leistung:
-7.05%
6M Leistung:
-17.67%
1J Leistung:
-8.21%
1-Tages-Spanne:
$22.96
$23.55
1-Wochen-Bereich:
$22.58
$23.55
52-Wochen-Spanne:
$20.10
$30.11
Tema Oncology Etf Stock (CANC) Company Profile
Firmenname
Tema Oncology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CANC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
23.20 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
252.60 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
513.88 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
516.38 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
202.27 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
433.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Aktie (CANC) Neueste Nachrichten
(CANC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
(CANC) Investment Analysis and Advice - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (CANC) - Stock Traders Daily
How To Trade (CANC) - Stock Traders Daily
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
When (CANC) Moves Investors should Listen - Stock Traders Daily
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
(CANC) Long Term Investment Analysis - Stock Traders Daily
(CANC) Trading Report - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
Trading (CANC) With Integrated Risk Controls - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Shares Sold by Jane Street Group LLC - Defense World
Reshoring ETF Gets Boost From Trump Trade - etf.com
Long Term Trading Analysis for (CANC) - Stock Traders Daily
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
(CANC) Investment Analysis - Stock Traders Daily
Pacer Data and Digital Revolution ETF (TRFK) Institutional Ownership 2024 - MarketBeat
The 5 Best Biotech ETFs of 2024 - TradingView
5 Small-cap Biotech ETFs to Watch - Investing News Network
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - Opto RoW
9 Best Biotech ETFs for 2024 - MSN
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
5 Best Biotech ETFs To Buy - Insider Monkey
Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld
Sanofi CEO under pressure to woo investors after spending shock - Reuters.com
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Nasdaq
Royalties and cancer treatments: Thematic ETFs take new directions - Investment News
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - ETF.com
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Getting in on global luxury - ETF Strategy
Biotechnology ETF List - ETFdb.com
Finanzdaten der Tema Oncology Etf-Aktie (CANC)
Es liegen keine Finanzdaten für Tema Oncology Etf (CANC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.86%
Kapitalisierung:
|
Volumen (24h):